日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial

新辅助帕博西尼联合阿那曲唑治疗内分泌耐药的雌激素受体阳性/HER2阴性乳腺癌疗效的生物标志物:一项II期试验

Kong, Tim; Mabry, Alex; Highkin, Maureen; Wang, Anthony Z; Hoog, Jeremy; Guo, Zhanfang; Gonzales-Gonzales, Adrian; Thomas, Shana; Song, Yingduo; Gao, Feng; Opyrchal, Mateusz; Peterson, Lindsay; Ademuyiwa, Foluso; Margenthaler, Julie; Aft, Rebecca; Glover-Collins, Katherine; Nehring, Leslie; Tao, Yu; Sanati, Souzan; Hagemann, Ian S; Boulos, Fouad; Holt, Matthew; Ding, Li; Zhu, Wenge; Oh, Stephen T; Wang, Jianxin; Witkiewicz, Agnieszka K; Knudsen, Erik S; Bose, Ron; Weber, Jason D; Goetz, Matthew; Northfelt, Donald; Luo, Jingqin; Ma, Cynthia X

Iron diminishes immunosuppressive macrophages and enhances anti-PD-1 immunotherapy in breast cancer models.

铁能减少免疫抑制性巨噬细胞,并增强乳腺癌模型中的抗PD-1免疫疗法。

Wang Qingfei, Adams Elizabeth L, Poole Rylee A, Soleimani Tahereh, Wang Grace Xiyu, Li Hudie, Capitano Maegan L, Masood Ashiq, Abrams Scott I, Lee Kelvin P, Zhang Siyuan, Opyrchal Mateusz

A phase I study targeting the APE1/Ref-1 redox signaling protein with APX3330: first clinical agent targeting APE1/Ref-1 in cancer

APX3330 靶向 APE1/Ref-1 氧化还原信号蛋白的 I 期研究:首个靶向 APE1/Ref-1 的癌症临床药物

Kelley, Mark R; Wan, Jun; Liu, Sheng; Kpenu, Eyram; Wireman, Randall; Mosley, Amber L; Liu, Hao; Lakhani, Nehal J; Shahda, Safi; O'Neil, Bert; Opyrchal, Mateusz; Messmann, Richard A

Forward genetics identifies HN1L/JPT2 as a novel carboplatin resistance gene in ovarian cancer

正向遗传学研究发现 HN1L/JPT2 是卵巢癌中一种新的卡铂耐药基因。

Wei, Han; Motolani, Aishat; Nephew, Kenneth P; Jiang, Guanglong; Alipourgivi, Faranak; Sun, Steven; Huang, Xiumei; Opyrchal, Mateusz; Sandusky, George; Liu, Yunlong; Lu, Tao

Reprogramming intratumoral T(reg) cells by morpholino-mediated splicing of FOXP3 for cancer immunotherapy

利用吗啉代寡核苷酸介导的FOXP3剪接重编程肿瘤内T(reg)细胞用于癌症免疫治疗

Li, Yujing; Singh, Naresh; Dong, Chuanpeng; Sharma, Samantha; Zhou, Zhuolong; Du, Jianguang; Haouili, Maya; Jiao, Yile; Hopewell, Emily; Liu, Yunlong; Opyrchal, Mateusz; Zhang, Xinna; Zhou, Baohua; Lu, Xiongbin

Targeting PARP1: A Promising Approach for Next-Generation Poly (ADP-ribose) Polymerase Inhibitors

靶向PARP1:一种有前景的下一代聚(ADP-核糖)聚合酶抑制剂策略

Ray, Alo; Opyrchal, Mateusz

A Phase I study targeting the APE1/Ref-1 redox signaling protein with APX3330: First clinical agent targeting APE1/Ref-1 in Cancer

一项针对 APE1/Ref-1 氧化还原信号蛋白的 I 期研究,使用 APX3330:首个针对癌症中 APE1/Ref-1 的临床药物

Kelley, Mark R; Wan, Jun; Liu, Sheng; Kpenu, Eyram; Wireman, Randall; Mosley, Amber L; Liu, Hao; Lakhani, Nehal J; Shahda, Safi; O'Neil, Bert; Opyrchal, Mateusz; Messmann, Richard A

A phase I study of the CDK4/6 inhibitor ribociclib combined with gemcitabine in patients with advanced solid tumors

一项针对晚期实体瘤患者的 CDK4/6 抑制剂 ribociclib 联合吉西他滨的 I 期研究

Norman, Aurora; Seetharam, Mahesh; Allred, Jacob; Kong, Jianping; Opyrchal, Mateusz; Ma, Wen Wee; Lou, Yanyan; Dy, Grace K; Mahipal, Amit; Weroha, S John; Wahner Hendrickson, Andrea E; Reid, Joel M; Adjei, Alex A

Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer Cells

抑制谷氨酸至谷胱甘肽通量促进结直肠癌细胞中的肿瘤抗原呈递

Tao Yu, Kevin Van der Jeught, Haiqi Zhu, Zhuolong Zhou, Samantha Sharma, Sheng Liu, Haniyeh Eyvani, Ka Man So, Naresh Singh, Jia Wang, George E Sandusky, Yunlong Liu, Mateusz Opyrchal, Sha Cao, Jun Wan, Chi Zhang, Xinna Zhang

Systemic chemokine-modulatory regimen combined with neoadjuvant chemotherapy in patients with triple-negative breast cancer

全身趋化因子调节方案联合新辅助化疗治疗三阴性乳腺癌

Gandhi, Shipra; Slomba, Ronald T; Janes, Cayla; Fitzpatrick, Victoria; Miller, Janine; Attwood, Kristopher; Ioannou, Giorgio; Ozbey, Sinem; De Souza, Igor; Roudko, Vladimir; Kumar, Prasanna; Kalathil, Suresh; Kokolus, Kathleen M; Wang, Jianming; Cortes Gomez, Eduardo; Takabe, Kazuaki; Edge, Stephen; Young, Jessica; Cappuccino, Helen; Opyrchal, Mateusz; O'Connor, Tracey; Levine, Ellis G; Gnjatic, Sacha; Kalinski, Pawel